What drugs does PERRIGO make?

PERRIGO has 31 FDA-approved drugs.

What therapeutic areas does PERRIGO focus on?

PERRIGO focuses primarily on Immunology and Dermatology and 1 other therapeutic areas.

← Back

Data updated: Jun 28, 2026

PERRIGO

Generics

Immunology Dermatology Gastroenterology

PERRIGO is a generic drug manufacturer focused on Immunology, Dermatology, Gastroenterology.

1983

Since

Drugs

Trials

New Drugs (2yr)

Modality:

PERRIGO's Key Drugs

PERRIGO's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

PERRIGO's Recent FDA Approvals

PERRIGO secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.

FAMOTIDINE NDA

2025-07-16

famotidine

1 INDICATIONS AND USAGE Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer (GU). • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. Famotidine tablets are indicated in adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of duodenal ulcer recurrence. Famotidine tablets are a histamine-2 (H 2 ) receptor antagonist indicated ( 1 ): In adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer. • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. In adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of DU recurrence.

PERRIGO's Therapeutic Areas

PERRIGO's approved drugs and pipeline span 3 therapeutic areas, led by Immunology and Dermatology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Immunology 33%

1 drugs

Dermatology 33%

1 drugs

Gastroenterology 33%

1 drugs

PERRIGO's Top Competitors

PERRIGO's closest competitors by therapeutic-area and drug-target overlap include BAUSCH, Pfizer, and PF PRISM CV. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

BAUSCH specialty

Dermatology, Immunology, Gastroenterology

Pfizer big-pharma

Immunology, Dermatology

PF PRISM CV big-pharma

Dermatology, Immunology, Gastroenterology

MALLINCKRODT specialty

Immunology, Gastroenterology, Dermatology

VALEANT PHARM INTL big-pharma

Dermatology, Immunology, Gastroenterology